Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Guangxi Lugang Biopharmaceutical Technology is a specialized biotechnology firm headquartered in Liuzhou, China, focusing on the deep processing and pharmaceutical application of deer-derived biological resources. The company leverages modern extraction and purification technologies to develop bioactive peptides, proteins, and other medicinal components from deer antler velvet and related tissues. Their business model integrates high-standard deer breeding with advanced R&D and manufacturing to produce health supplements and potential biopharmaceutical candidates. Key focus areas include bone health, immune modulation, and the modernization of traditional animal-based medicines. Lugang Biopharmaceutical aims to establish a comprehensive industrial chain for the deer industry in the Guangxi region.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Guangxi Lugang Biopharmaceutical Technology.